Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Water in Protein-Ligand Binding: Decisive Factor, Annoying Feature, or Indispensable Control Element: In Any Case, a Major Challenge.

ChemMedChem·2026
Same author

Thermodynamic Data Remain a Hot Tip for Decoding Binding Affinity and Water Impact on Protein-Ligand Complex Formation to Assist Lead Optimization.

Journal of medicinal chemistry·2026
Same author

Natural Product-like Fragments Unlock Novel Chemotypes for a Kinase Target─Exploring Options beyond the Flatland.

Journal of chemical information and modeling·2025
Same author

Development of a Crystallographic Screening to Identify Sudan Virus VP40 Ligands.

ACS omega·2024
Same author

Fragment-Based Design, Synthesis, and Characterization of Aminoisoindole-Derived Furin Inhibitors.

ChemMedChem·2024
Same author

Crystallographic Fragment Screening on the <i>Shigella</i> Type III Secretion System Chaperone IpgC.

ACS omega·2023

Related Experiment Video

Updated: Jul 8, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Use of 3D QSAR models for database screening: a feasibility study.

Alexander Hillebrecht1, Gerhard Klebe

  • 1Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 6, 35032 Marburg, Germany.

Journal of Chemical Information and Modeling
|January 24, 2008
PubMed
Summary

3D quantitative structure-activity relationship (QSAR) methods like CoMFA and CoMSIA show strong applicability for database screening. These methods, exemplified with human carbonic anhydrase (hCA) isozymes, offer robust prediction of compound activity and selectivity.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Jul 8, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Pharmacology

Background:

  • 3D quantitative structure-activity relationship (QSAR) methods, including Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA), are valuable tools for drug discovery.
  • Assessing the scope and applicability of these methods for large-scale database screening is crucial for efficient lead identification.
  • Human carbonic anhydrase (hCA) isozymes serve as a relevant model system for studying enzyme inhibition and selectivity.

Purpose of the Study:

  • To evaluate the applicability and scope of 3D QSAR (CoMFA, CoMSIA) methods for screening chemical databases.
  • To establish a user-friendly protocol for molecular alignment using FlexS for training and test set molecules.
  • To assess the predictive power of 3D QSAR models against 2D QSAR models for human carbonic anhydrase (hCA) isozymes.

Main Methods:

  • Utilized 3D QSAR techniques (CoMFA, CoMSIA) for model development.
  • Implemented a minimal-intervention protocol with FlexS for molecular alignment.
  • Developed models for human carbonic anhydrase II (hCA II) affinity and selectivity between hCA I and hCA II.
  • Predicted the activity of 663 external compounds.
  • Compared predictive performance against 2D QSAR models using MACCS and VSA descriptors.

Main Results:

  • 3D QSAR models demonstrated significant applicability and scope for database screening.
  • The established FlexS protocol facilitated efficient molecular alignment.
  • Models accurately predicted compound affinity and selectivity for hCA isozymes.
  • 3D QSAR models outperformed 2D QSAR models in predictive accuracy for external datasets.
  • Both numerical (absolute accuracy) and categorical (activity class assignment) criteria confirmed the superiority of 3D QSAR.

Conclusions:

  • 3D QSAR methods (CoMFA, CoMSIA) are highly effective for large-scale database screening in drug discovery.
  • The developed protocol enhances the efficiency and ease of use for QSAR modeling.
  • 3D QSAR models provide superior predictive power compared to traditional 2D QSAR approaches for hCA targets.
  • These findings support the broader application of 3D QSAR in identifying potential drug candidates.